Scope Biosciences develops scopeDx®, a CRISPR-Cas molecular diagnostics platform for rapid, accurate, on-site detection of pathogens
Scope Biosciences develops scopeDx®, a CRISPR-Cas molecular diagnostics platform for rapid, accurate, on-site detection of pathogens. Its current focus is crop and agricultural pathogen testing, enabling growers to test crude samples in the field and receive results in under an hour. The company also identifies healthcare applications, including veterinary and transplant diagnostics.